Microfluidics for Assessing Breast Cancer Susceptibility

Thursday, 30 November 2023 at 10:00

Add to Calendar ▼2023-11-30 10:00:002023-11-30 11:00:00Europe/LondonMicrofluidics for Assessing Breast Cancer SusceptibilityLab-on-a-Chip and Microfluidics World Congress 2023 in Laguna Hills, CaliforniaLaguna Hills, CaliforniaSELECTBIOenquiries@selectbiosciences.com

More than 75% of women with newly diagnosed breast cancer are over the age of 50.  Women who carry germline mutations have a lifetime risk as high 80% for developing breast cancer.  Microfluidic applications in breast cancer have focused on diagnosis and therapeutic screening, and more recently, on recapitulating tumor microenvironments to study breast cancer biology.  In this talk, I will describe how my lab has taken a different path:  using microfluidics to assess a woman’s susceptibility for developing breast cancer.

Lydia Sohn, Almy C. Maynard and Agnes Offield Maynard Chair in Mechanical Engineering, University of California-Berkeley

Lydia Sohn

Lydia L. Sohn received her A.B. (Chemistry and Physics, 1988), M.S. (Physics, 1990), and Ph.D. (Physics, 1992) from Harvard University. She was an NSF/NATO postdoc at Delft University of Technology and a postdoc at AT&T Bell Laboratories (1993-1995). Sohn was an Assistant Professor of Physics at Princeton University prior to joining the Mechanical Engineering Dept. at UC Berkeley in 20013. Her work focuses on developing quantitative techniques to probe single cells. Sohn has received numerous awards including the NSF CAREER, Army of Research Young Investigator Award, DuPont Young Professor Award, and a Bakar Fellowship. In 2014, she was one of five winners in the “Identifying Platform Technologies for Advancing Life Sciences Research” competition for her work on Node-Pore Sensing. Most recently, she was elected a Fellow of the American Institute for Medical and Biological Engineering.